Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Intel Strategy for Achieving Wealth and Off Topic -- Ignore unavailable to you. Want to Upgrade?

To: Sonki who wrote (16539)	1/31/1998 11:56:00 PM
From: margaret tasset	Read Replies (1) \| Respond to of 27012

Good evening Sonki, You said something about being interested in Novartis. I got some stuff on it and you probably already know most of this but thought I would post it for you, just in case there is something about it that you didn't know. "With long-standing expertise in cardiovascular healthcare and one of the world's largest clinical research and development operations, Novartis has a powerful base to back up cholesterol lowering claims with scientific evidence. Further clinical trials are planned and Novartis is confident in its ability to speed development and shorten time-to-market. It also has the strength of its Nutrition distribution channels to launch and market nutraceuticals. Novartis Nutrition is one of the largest specialized nutrition companies in the world. It is the number one health food marketer in Europe, holds the number two position worldwide in medical nutrition, and is a world leader in jarred infant and baby food. It develops manufactures and markets a range of value added specialized health and medical nutrition products, and is owner of the leading US infant and baby nutrition brand, Gerber. The parent company, Novartis, is a world leader in life sciences with core business in healthcare, agribusiness and nutrition. In 1997, Novartis Group sales were US$21.6 billion, of which US$13.0 billion were in healthcare, US$5.8 billion in agribusiness and US$2.8 billion in nutrition. Headquartered in Basel, Switzerland, Novartis employs about 87,000 people and operates in over 100 countries. The stock looks strong and could still go higher. We expect it to encounter some resistance at around $5.50." Hope all is well. Health to you, Margaret :) :) :)